James O. Jones
- Oncology top 1%
- Immunology top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Biomedical Engineering
- Co-authors
- Edward W. RobertsDouglas T. FearonMatthew KramanDavid A. TuvesonTobias JanowitzAndrew DeonarineChristine FeigR. J. Wells
- Topics
- Renal cell carcinoma treatment (7 papers)Cancer Immunotherapy and Biomarkers (6 papers)Renal and related cancers (5 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
James O. Jones
17 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 2.3k
- Immunology 1.3k
- Molecular Biology 842
- Cancer Research 552
- Biomedical Engineering 240
Countries citing papers authored by James O. Jones
This map shows the geographic impact of James O. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O. Jones more than expected).
Fields of papers citing papers by James O. Jones
This network shows the impact of papers produced by James O. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O. Jones. The network helps show where James O. Jones may publish in the future.
Co-authorship network of co-authors of James O. Jones
This figure shows the co-authorship network connecting the top 25 collaborators of James O. Jones. A scholar is included among the top collaborators of James O. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O. Jones. James O. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 129 | |
| 11 | 12 | |
| 12 | 20 | |
| 13 | 16 | |
| 14 | 30 | |
| 15 | 22 | |
| 16 | 300 | |
| 17 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancerbreakdown → | 1490 |
| 18 | Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αbreakdown → | 918 |
About James O. Jones
James O. Jones is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 3.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Oncology (2.3k citations), Immunology (1.3k citations) and Cancer Research (552 citations). James O. Jones has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Edward W. Roberts, Douglas T. Fearon, Matthew Kraman, David A. Tuveson, Tobias Janowitz, Andrew Deonarine, Christine Feig, R. J. Wells, Otávia L. Caballero and Qi Zhao. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.